James P Mackin insider trades

Open-market stock purchases and sales by James P Mackin, President & CEO at Artivion, Inc, from SEC Form 4 filings since Jan 7, 2010.

Track record: 50% of 4 scored buys are up 5% or more since purchase, averaging +10%.

Recent trades

DateStockTradeValue
Aug 19, 2026AORT Artivion, IncSold$2M
Mar 3, 2026AORT Artivion, IncSold$676K
Mar 2, 2026AORT Artivion, IncBought (not open market)—
Mar 2, 2026AORT Artivion, IncSold$567K
Feb 24, 2026AORT Artivion, IncSold$497K
Feb 24, 2026AORT Artivion, IncBought (not open market)—
Feb 23, 2026AORT Artivion, IncSold$788K
Dec 3, 2025AORT Artivion, IncSold$1.4M
Dec 3, 2025AORT Artivion, IncBought (not open market)—
Dec 2, 2025AORT Artivion, IncSold$1.4M
Dec 2, 2025AORT Artivion, IncBought (not open market)—
Nov 13, 2025AORT Artivion, IncSold$1.6M
Nov 10, 2025AORT Artivion, IncSold$784K

Companies traded

  • AORT Artivion, Inc: 35 sales, last Aug 19, 2026
  • CRY Cryolife Inc: 4 buys, 10 sales, last Apr 30, 2021
  • WMGI Wright Medical Group NV: other filings, last Nov 11, 2020
  • MDT Medtronic Inc: 4 sales, last Oct 29, 2010

Get free alerts when James P Mackin files a new trade →